Fort Lauderdale, FL, May 07, 2018 (GLOBE NEWSWIRE) -- OmniComm Systems, Inc. (OTCQX: OMCM), a global provider of clinical data management technology, today announced the launch of OmniComm AutoEncoder, a user-friendly tool for coding clinical data against medical dictionaries. OmniComm will showcase and demonstrate AutoEncoder at industry events around the globe, including Innovation Forum Europe, June 7-8 in Bonn, DIA China in Beijing on May 23-25, and DIA 2018 in Boston on June 24-28.
“We have taken the opportunity to build a state-of-the-art coding tool from scratch,” said Keith Howells, OmniComm’s chief technology officer. “It has sophisticated algorithms, including language-sensitive search capabilities, and it features a fresh, intuitive and responsive user interface. Coding professionals are going to feel really at home with this product.”
Coding is a unique and necessary process required by regulators during clinical trials or when monitoring the safety of approved products. Regulatory agencies require that adverse events be coded against the MedDRA dictionary, and that medications be coded against the WHO Drug dictionary. The coding process is performed by specialist medical professionals, who must ensure consistent and accurate decisions based on the content of the source term, any relevant related data, and prior decisions for the trial or drug project.
The OmniComm AutoEncoder provides a modern and sophisticated tool for performing these coding activities. Out of the box, AutoEncoder is fully integrated with OmniComm’s TrialMaster® product for Electronic Data Capture, and its open interfaces also allow for integration with any third-party EDC or safety reporting system.
“We are confident that our cutting-edge coding solution will be well received by the industry,” said Stephen Johnson, president and CEO of OmniComm. “AutoEncoder deploys the latest in technology and intuitive design. We’ve leveraged our previous 10 years of experience offering coding solutions and aligned this new technology to match the changing industry regulations. The result is a functionally rich, easy-to-use, innovative solution that is fully integrated with our TrialMaster EDC solution and easily integrated with third-party EDC and safety systems.”
About OmniComm Systems, Inc.
OmniComm Systems provides a role in enhancing patient lives by shortening time to market of essential life-saving treatments. OmniComm Systems is dedicated to providing the latest eClinical technology enabling the world’s life science organizations to maximize the value of their clinical research investments. OmniComm’s solutions provide better trial oversight and study delivery, connecting patients to better healthcare. OmniComm provides comprehensive solutions for clinical research with an extensive global experience from more than 6,000 clinical trials. Please visit www.omnicomm.com for more information.
Trademarks
OmniComm, TrialMaster and TrialOne are registered trademarks of OmniComm Systems, Inc. Other names may be trademarks of their respective owners.
Contact Info
Kuno van der Post
OmniComm Systems, Inc.
+1.954.473.1254
KvanderPost@omnicomm.com
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.